SPECIAL EMPHASIS PANELS

To view other meetings from ZAI1 choose calendar year:

Study Section Panel Name Meeting Rosters
ZAI1 JHM-I(S1) PAR21-082, NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED) 05/14/21
ZAI1 MMF-I(S1) NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) 05/13/21
ZAI1 KJK-I(S1) PAR-20-072, NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) 05/05/21
ZAI1 LAR-I(S2) NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) 04/30/21
ZAI1 LG-W(M3) NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED) 04/22/21
ZAI1 JTS-I(M1) CLINICAL TRIALS IN ORGAN TRANSPLANTATION IN CHILDREN AND ADULTS (CTOT-CA) (U01 CLINICAL TRIAL OPTIONAL) 04/22/21
ZAI1 LAR-X(M2) EMERGENCY AWARDS: NOTICE OF SPECIAL INTEREST (NOSI) ON PAN-CORONAVIRUS VACCINE DEVELOPMENT PROGRAM PROJECTS 04/22/21
ZAI1 PP-D(M1) NIAID RESEARCH EDUCATION PROGRAM (R25 CLINICAL TRIAL NOT ALLOWED) 04/15/21
ZAI1 KP-D(M1) NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (PARENT R13 CLINICAL TRIAL NOT ALLOWED) 04/13/21
ZAI1 LAR-X(M1) NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) 04/12/21
ZAI1 ZL-E(M2) EXPANDING EXTRAMURAL RESEARCH OPPORTUNITIES AT THE NIH CLINICAL CENTER (U01 CLINICAL TRIAL OPTIONAL) 04/07/21
ZAI1 LG-M(M2) MULTIDISCIPLINARY STUDIES TO IMPROVE UNDERSTANDING OF INFLUENZA TRANSMISSION (U19 CLINICAL TRIAL OPTIONAL) 04/07/21
ZAI1 JBS-A(M1) MARTIN DELANEY COLLABORATORIES FOR HIV CURE RESEARCH (UM1 CLINICAL TRIAL NOT ALLOWED); MARTIN DELANEY COLLABORATORY FOR PEDIATRIC HIV CURE RESEARCH (UM1 CLINICAL TRIAL NOT ALLOWED) 03/30/21
ZAI1 MMF-I(C4) AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (AD-SCCC) 03/23/21
ZAI1 TC-I(M1) ASTHMA AND ALLERGIC DISEASES COOPERATIVE RESEARCH CENTERS (U19 CLINICAL TRIAL OPTIONAL) 03/22/21
ZAI1 SB-I(M1) MUCOSAL IMMUNOLOGY STUDIES TEAM (MIST) (U01 CLINICAL TRIAL NOT ALLOWED) 03/22/21
ZAI1 KGH-I(C4) NIAID/DAIT REGULATORY MANAGEMENT CENTER (RMC) 03/19/21
ZAI1 KJK-I(C1) RFP-NIH-NIAID-DAIT-75N93020R00018: TRANSPLANTATION STATISTICAL AND CLINICAL COORDINATING CENTER (T-SCCC) 03/18/21
ZAI1 LAR-I(C1) ALLERGY AND ASTHMA STATISTICAL & CLINICAL COORDINATING CENTER (AA-SCCC) 03/10/21
ZAI1 JHM-D(M2) NIAID NEW INNOVATORS AWARDS (DP2 CLINICAL TRIAL NOT ALLOWED) 03/02/21
ZAI1 ESB-M(M1) LIMITED COMPETITION: STIMULATING ACCESS TO RESEARCH IN RESIDENCY TRANSITION SCHOLAR (STARRTS) (K38) (CLINICAL TRIAL NOT ALLOWED) 02/26/21
ZAI1 TCB-I(M1) COLLABORATIVE CROSS MOUSE MODEL GENERATION AND DISCOVERY OF IMMUNOREGULATORY MECHANISMS (R21) 02/25/21
ZAI1 MC-M(C1) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: DEVELOPMENT OF PRIORITY DIAGNOSTICS FOR CHAGAS DISEASE (TOPIC 96) 02/24/21
ZAI1 LK-M(M1) TUBERCULOSIS RESEARCH UNITS (U19 CLINICAL TRIALS OPTIONAL) 02/24/21
ZAI1 ZL-M(M1) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 02/23/21
ZAI1 MC-M(C2) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: PEDIATRIC FORMULATIONS OF SELECT SECOND LINE DRUGS FOR TREATING TUBERCULOSIS (TOPIC 97) 02/22/21
ZAI1 MC-M(C3) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE II: PEDIATRIC FORMULATIONS OF SELECT SECOND LINE DRUGS FOR TREATING TUBERCULOSIS (TOPIC 97) 02/22/21
ZAI1 KGH-I(M2) NIAID TRIAL PLANNING GRANT (R34 CLINICAL TRIALS NOT ALLOWED), NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED) 02/12/21
ZAI1 TC-I(C2) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE II: ADJUVANT DEVELOPMENT FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES (TOPIC 091) (FOR SBIRS PHASE II) 02/08/21
ZAI1 TC-I(C1) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: 91. ADJUVANT DEVELOPMENT FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES (TOPIC 091) (FOR SBIRS PHASE I) 02/08/21
ZAI1 MFH-W(M1) EMERGENCY AWARDS: RAPID INVESTIGATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) AND CORONAVIRUS DISEASE 2019 (COVID-19) 02/08/21
ZAI1 TCB-I(M2) NONHUMAN PRIMATE REAGENT RESOURCE (U24 CLINICAL TRIAL NOT ALLOWED) 02/08/21
ZAI1 FDS-M(C1) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: IMPROVING TECHNOLOGIES TO MAKE LARGE-SCALE HIGH TITER PHAGE PREPS (TOPIC 95) 02/05/21
ZAI1 KSW-A(C1) HHS-NIH-CDC-SBIR PHS 2021-1: POINT-OF-CARE HIV VIRAL LOAD, DRUG RESISTANCE, AND ADHERENCE ASSAYS (TOPIC 87) 02/05/21
ZAI1 FDS-M(C2) HHS-NIH-CDC-SBIR PHS 2018-1 PHASE II: IMPROVING TECHNOLOGIES TO MAKE LARGE-SCALE HIGH TITER PHAGE PREPS (TOPIC 95) 02/05/21
ZAI1 LR-D(C1) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 100 02/02/21
ZAI1 MMF-I(C1) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: ADJUVANT DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASE (TOPIC 092) (FOR SBIRS PHASE I) 02/01/21
ZAI1 MMF-I(C3) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE II: ADJUVANT DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASE (TOPIC 092) (FOR SBIRS PHASE II) 02/01/21
ZAI1 MMF-I(C2) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: PRODUCTION OF ADJUVANTS MIMICS (TOPIC 093) (FOR SBIRS PHASE I) 02/01/21
ZAI1 KGH-I(C3) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE II: REAGENTS FOR IMMUNOLOGIC ANALYSIS OF NON-MAMMALIAN AND UNDERREPRESENTED MAMMALIAN MODELS (TOPIC 094) (FOR SBIRS PHASE II) 01/29/21
ZAI1 SAS-M(C2) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 099 PHASE I 01/28/21
ZAI1 SAS-M(C3) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 099 PHASE II 01/28/21
ZAI1 KGH-I(C2) HHS-NIH-CDC-SBIR PHS 2021-1 PHASE I: REAGENTS FOR IMMUNOLOGIC ANALYSIS OF NON-MAMMALIAN AND UNDERREPRESENTED MAMMALIAN MODELS (TOPIC 094) (FOR SBIRS PHASE I) 01/28/21
ZAI1 SAS-M(C1) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 098 01/27/21
ZAI1 KKS-E(C7) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS, TASK AREA F 01/27/21
ZAI1 RAO-E(C2) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS, TASK AREA G 01/25/21
ZAI1 DNV-A(C2) HHS-NIH-CDC-SBIR PHS 2021-1: PARTICLE-BASED CO-DELIVERY OF HIV IMMUNOGENS AS NEXT-GENERATION HIV VACCINES (TOPIC 89) 01/22/21
ZAI1 JHM-I(M1) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 01/22/21
ZAI1 KKS-E(C6) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS, TASK AREA E 01/22/21
ZAI1 DNV-A(C4) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 89 01/22/21
ZAI1 IS-W(M1) EMERGENCY AWARDS: RAPID INVESTIGATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) AND CORONAVIRUS DISEASE 2019 (COVID-19) 01/21/21
ZAI1 DNV-A(C3) A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS (N01), TOPIC 88 PHASE II 01/21/21
ZAI1 KKS-E(C5) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS, TASK AREA D 01/21/21
ZAI1 BLG-W(M1) EMERGENCY AWARDS: RAPID INVESTIGATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) AND CORONAVIRUS DISEASE 2019 (COVID-19) 01/21/21
ZAI1 DNV-A(C1) HHS-NIH-CDC-SBIR PHS 2021-1: THERAPEUTIC TARGETING OF INTRACELLULAR HIV-1 PROTEINS OR NUCLEIC ACIDS (TOPIC 88) 01/21/21
ZAI1 PG-M(M1) NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44); NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01); NIAID CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRIAL NOT ALLOWED) 01/19/21
ZAI1 KKS-E(C4) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS (N01), TASK AREA C 01/19/21
ZAI1 RAO-E(C1) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS, TASK AREA B 01/15/21
ZAI1 KGH-I(C1) NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC) 01/15/21
ZAI1 FDS-W(M1) EMERGENCY AWARDS: RAPID INVESTIGATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) AND CORONAVIRUS DISEASE 2019 (COVID-19) (R21, R01 CLINICAL TRIALS NOT ALLOWED) 01/14/21
ZAI1 KGH-I(M1) NIAID CLINICAL TRIAL PLANNING GRANT (R34 CLINICAL TRIALS NOT ALLOWED) 01/14/21
ZAI1 AMC-W(M1) EMERGENCY AWARDS: RAPID INVESTIGATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) AND CORONAVIRUS DISEASE 2019 (COVID-19) 01/14/21
ZAI1 RCU-A(J4) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 01/13/21
ZAI1 RCU-A(J5) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 01/12/21
ZAI1 KKS-E(C3) COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS (N01), TASK AREA A 01/08/21
ZAI1 RCU-A(J1) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 01/06/21